Harrow Health (HROW) Misses Q3 EPS by 23c

Harrow Health (NASDAQ: HROW) reported Q3 EPS of ($0.24), $0.23 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $22.8 million versus the consensus estimate of $23.14 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown